Glizid-MR 30 Tablet is an oral antidiabetic medication used to manage blood sugar levels in adults with type 2 diabetes. The ""MR"" (Modified Release) formula ensures that the active ingredient, Gliclazide, is released slowly and consistently into the bloodstream throughout the day. This provides stable glucose control and helps reduce the risk of blood sugar spikes after meals.
Gliclazide works by stimulating the beta cells in the pancreas to produce more insulin. This helps the body process sugar more effectively and helps reduce the risk of long-term complications of diabetes, such as nerve damage, kidney problems, and vision loss. The modified-release technology makes it a convenient once-daily option for patients who require steady, around-the-clock sugar management.
Take the tablet exactly as prescribed, usually with breakfast. It must be swallowed whole and not crushed or chewed to maintain the slow-release effect. Regular blood sugar monitoring and periodic HbA1c tests are required to ensure the treatment is effective. Always carry a source of quick-acting sugar, such as candy or glucose tablets, in case you experience symptoms of low blood sugar (hypoglycemia).








































































